Clinical Trial Update: A Study of GC3107(BCG Vaccine) in Healthy Infants [Phase 3]

View source ↗

Summary

Phase 3 trial of GC3107 (BCG vaccine) in healthy infants completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GC3107 (BCG vaccine)

Snippet

Sponsor: Green Cross Corporation | Conditions: BCG Vaccination Reaction, Tuberculosis | Phase 3 | Status: COMPLETED